Lpl Financial LLC Novo Cure LTD Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$11.83 - $24.05 $36,874 - $74,963	-3,117 Reduced 17.54%	14,651 $250,000
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $36,514 - $50,832	-2,940 Reduced 14.2%	17,768 $277,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $57,252 - $81,172	5,144 Added 33.05%	20,708 $309,000
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $125,582 - $329,313	-7,776 Reduced 33.32%	15,564 $251,000
Q2 2023 Jul 31, 2023	SELL	$40.29 - $82.51 $29,250 - $59,902	-726 Reduced 3.02%	23,340 $968,000
Q1 2023 May 10, 2023	SELL	$56.44 - $118.81 $43,458 - $91,483	-770 Reduced 3.1%	24,066 $1.45 Million
Q4 2022 Feb 07, 2023	BUY	$63.98 - $85.37 $170,826 - $227,937	2,670 Added 12.05%	24,836 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $190,711 - $251,243	2,805 Added 14.49%	22,166 $1.68 Million
Q2 2022 Aug 12, 2022	BUY	$56.6 - $89.9 $36,903 - $58,614	652 Added 3.48%	19,361 $1.35 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $257,863 - $362,337	-4,287 Reduced 18.64%	18,709 $1.55 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $39,116 - $63,556	521 Added 2.32%	22,996 $1.73 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $620,928 - $1.04 Million	5,345 Added 31.2%	22,475 $2.61 Million
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $39,511 - $68,350	-303 Reduced 1.74%	17,130 $3.8 Million
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $895,577 - $1.37 Million	-7,216 Reduced 29.28%	17,433 $2.3 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $102,065 - $158,467	-910 Reduced 3.56%	24,649 $4.27 Million
Q3 2020 Nov 09, 2020	BUY	$58.05 - $111.31 $87,655 - $168,078	1,510 Added 6.28%	25,559 $2.85 Million
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $216,845 - $282,088	3,791 Added 18.71%	24,049 $1.43 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $263,513 - $442,269	4,619 Added 29.54%	20,258 $1.36 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $26,705 - $36,675	391 Added 2.56%	15,639 $1.32 Million
Q3 2019 Nov 13, 2019	SELL	$61.86 - $97.8 $539,171 - $852,424	-8,716 Reduced 36.37%	15,248 $1.14 Million
Q2 2019 Aug 09, 2019	BUY	$42.22 - $63.23 $433,514 - $649,245	10,268 Added 74.97%	23,964 $1.52 Million
Q1 2019 May 08, 2019	SELL	$31.96 - $56.12 $2,780 - $4,882	-87 Reduced 0.63%	13,696 $660,000
Q4 2018 Feb 07, 2019	BUY	$28.72 - $52.63 $395,847 - $725,399	13,783 New	13,783 $461,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$195 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$191 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$128 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$69.4 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$48.8 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account